Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
- Sponsor
- Institut de Myologie, France
- Study ID
- NCT06866652
- Status
- Recruiting
Conditions
- Dyspnea
- Myasthenia Gravis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Individuals with MG (IwMG) experience shortness of breath that may be activity-related, occur at rest and even happen during sleep. Dyspnea is a complex, multidimensional and multifactorial symptom involving sensory perception, cognition and emotion. Identifying the cause(s) of dyspnea in MG may assist in finding therapeutic strategies, reducing discomfort, improving QoL and potentially limiting respiratory deterioration and incidence of MG crisis.
Key Dates
- First listed
- Mar 10, 2025
- Start date
- Apr 8, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
Dyspnea questionnaires [ Time Frame: baseline ]
Related Studies
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruiting · Sanford Health · Sioux Falls, South Dakota
- The EXPLORE MG Registry for Myasthenia GravisRecruiting · Yale University · New Haven, Connecticut
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisPHASE3 · Recruiting · Janssen Research & Development, LLC · Paradise Valley, Arizona